Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Driving Force

16/04/2021Driving Force

Helping organizations to reduce collisions, injuries, license violations and total cost of fleet ownership through a patented driver risk management program, eDrivingSM is a clear market leader in its field. As the global enterprise celebrates twenty-five year

One Wrong Click Could Expose Firms That Only Think They Are Cyber Secure, Expert Warns

19/05/2026One Wrong Click Could Expose Firms That Only Think They Are Cyber Secure, Expert Warns

In this exclusive interview with the Cyber Security Speakers Agency, Phillip Wylie explains where businesses are giving themselves false confidence, how hackers are changing tactics as defences improve, and why security teams need to keep learning before crimi

Green Data Centers: How Sustainable Practices Are Shaping the Industry

07/11/2024Green Data Centers: How Sustainable Practices Are Shaping the Industry

Green Data Centers: How Sustainable Practices Are Shaping the Industry In the recent past, there has been increased use of data centers as more firms embarked on cloud services, artificial intelligence, and data storage. Although tremendous improvements exist

7 Out of the Box Ways to Earn Extra Money Each Month

31/08/20227 Out of the Box Ways to Earn Extra Money Each Month

With the cost of living in the UK increasing significantly across energy, petrol and groceries, people are increasingly looking for extra work or side hustles to stay on top of their personal finances.

How Investors Can Travel to Regional Business Hubs Without Losing Valuable Time

27/07/2026How Investors Can Travel to Regional Business Hubs Without Losing Valuable Time

The most promising investment opportunities are not always found in the world’s largest financial centres. Many successful businesses operate from manufacturing corridors, logistics hubs, energy regions and smaller cities that sit well outside traditiona

A Trusted Partner in MedTech Manufacturing

15/07/2026A Trusted Partner in MedTech Manufacturing

Many organisations across the pharmaceutical, biotechnology, and medical technology sectors are facing increasing pressure around injectable drug delivery, device supply, time-to-market, and more.

Thanks for Voting

24/11/2015Thanks for Voting

Thanks for Voting

Transfer Pricing

01/07/2016Transfer Pricing

BDO is an international network of public accounting, tax and advisory firms which perform professional services under the name of BDO. We have representation in 157 territories, with 64.300 people working out of over 1.400 offices worldwide.

ON Semiconductor Extends Tender Offer to Acquire Fairchild Semiconductor

19/02/2016ON Semiconductor Extends Tender Offer to Acquire Fairchild Semiconductor

ON Semiconductor Corporation announced that it has extended its previously announced tender offer to purchase all of the outstanding shares of common stock of Fairchild Semiconductor International Inc. for $20.00 per share in cash (the “Offer”) pending the

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS